MUCINEX: GUAIFENESIN EXTENDED-RELEASE TAB.
GUAIFENESIN EXTENDED-RELEASE TAB. Key specifications include administration: ORAL, long_action_method: EXTENDED RELEASE, primary_container_type: BOX, METAL, total_primary_container_quantity: 14, primary_container_content_quantity: 14.0 TABLETS, active_medicament_medicinal_strength: 1200.0 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-238-9443, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| long_action_method | EXTENDED RELEASE |
| primary_container_type | BOX, METAL |
| total_primary_container_quantity | 14 |
| primary_container_content_quantity | 14.0 TABLETS |
| active_medicament_medicinal_strength | 1200.0 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | GUAIFENESIN TABLET EXTENDED RELEASE MAXIMUM STRENGTH 1200MG 14 TABLETS |
| NSN | 6505-01-238-9443 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| SUPPLEMENTARY FEATURES | USE PREFERRED NSN, 6505-01-539-3176 IN ACCORDANCE WITH THE JDF IN |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | SUSTAINED ACTING FOR 12 HRS AFTER ADMINISTRATION,W/THE FOLLOWING RELEASE RATES: 15-35% W/I 1 HR; 30-55% W/I 2 HRS; 45-75% W/I 4 HRS; 70-95% W/I 8 HRS; NOT LATER THAN 80% W/I 10 HRS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | GUAIFENESIN EXTENDED RELEASE TABLETS 600MG 100S BT |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 600.000 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.